Overview

Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia

Status:
Not yet recruiting

Trial end date:
2023-09-30

Target enrollment:

Participant gender:

Summary

Study is prospective randomised multicentric. The primary objective of the study is to compare the efficacy of two first-line therapy regimens and two second-line therapy regimens (ie, after failure of first-line treatment) in patients with H. pylori infection. The secondary objective of the study is to determine the primary resistance of H. pylori to antibiotics in Slovenia.

Phase:

N/A

Details

Lead Sponsor:

Slovenian Society for Gastroenterology and Hepatology

Collaborator:

KRKA

Treatments:

Amoxicillin
Bismuth
Bismuth tripotassium dicitrate
Clarithromycin
Esomeprazole
Levofloxacin
Metronidazole
Ofloxacin